Position in ZLAB
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$704,246
-$824,083 QoQ
Shares Held
37,440
-56.8% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZLAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026TD Asset Management Inc holds $1,314,505,240 across 121 Biotechnology names. ZLAB ranks #100 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
350,923 | $271,137,146 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
228,195 | $101,898,194 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
281,848 | $93,255,047 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
1,168,666 | $75,530,883 | |
| 5 | ARGX |
Argenx SE
|
80,824 | $59,021,726 | |
| 6 | ASND |
Ascendis Pharma A/S
|
217,992 | $49,861,310 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
529,954 | $39,794,245 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
317,811 | $30,907,119 |
All Filings in ZLAB
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $704,246 | 37,440 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,528,329 | 86,640 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $4,118,583 | 121,528 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $843,756 | 24,128 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $10,687,609 | 295,728 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $8,096,062 | 309,128 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $5,424,933 | 224,728 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $3,846,740 | 221,970 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $3,507,899 | 218,970 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $6,438,128 | 235,570 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $5,274,540 | 216,970 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $2,803,087 | 101,085 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $2,933,033 | 88,185 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $1,279,729 | 41,685 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $1,425,627 | 41,685 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $1,331,191 | 38,385 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $1,881,728 | 42,786 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $2,689,100 | 42,786 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $3,961,188 | 37,586 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $6,156,774 | 34,786 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $3,742,444 | 28,048 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,958,397 | 21,859 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,215,030 | 14,609 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $723,483 | 8,809 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $417,451 | 8,109 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||